Remark Pharma Private Limited, a active private limited company, was established on 06 June 2011 in Ranchi, Jharkhand, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24231JH2011PTC014896. Registered under ROC Roc Ranchi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.18 M.
It upholds a compliant status. Its leadership includes Pawan Kumar Arya (Director), Sangeeta Gupta (Director), Kanchan Arya (Director). Past directors included Kamal Bhushan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sri Bishwanath Bhawan, Mo- Madhukam, P.O.: Hehal, P.S.: Sukhdeonagar,, Ranchi, Jharkhand, 834005.
U24231JH2011PTC014896
014896
06 June 2011
₹1.00 M
₹0.18 M
Roc Ranchi
Unlisted
Active
Explore comprehensive insights into Remark Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pawan Kumar Arya | Director | 11 May 2016 | Current |
| Sangeeta Gupta | Director | 11 May 2016 | Current |
| Kanchan Arya | Director | 06 Jun 2011 | Current |
| Deepak Kumar | Director | 06 Jun 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 May 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Remark Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.5% increase. The company also saw a substantial fall in profitability, with a 165.94% decrease in profit. The company's net worth dipped by a decrease of 2.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Remark Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Remark Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Remark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remark Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Remark Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Remark Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ranchi. was completed.
Pawan Kumar Arya was appointed as a Director was appointed as a Director on 11 May 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.
The activity Sangeeta Gupta was appointed as a Director was appointed as a Director on 11 May 2016 & has been associated with this company since 9 years 6 months . was completed.
The activity Kanchan Arya was appointed as a Director was appointed as a Director on 06 Jun 2011 & has been associated with this company since 14 years 5 months . was completed.
The activity Deepak Kumar was appointed as a Director was appointed as a Director on 06 Jun 2011 & has been associated with this company since 14 years 5 months . was completed.
The CIN of Remark Pharma Private Limited is U24231JH2011PTC014896.
Remark Pharma Private Limited is headquartered at Sri Bishwanath Bhawan, Mo- Madhukam, P.O.: Hehal, P.S.: Sukhdeonagar,, Ranchi, Jharkhand, 834005.
Remark Pharma Private Limited was incorporated on 06 June 2011.
The current directors of Remark Pharma Private Limited are
The primary industry of Remark Pharma Private Limited is Pharma.
Remark Pharma Private Limited is unlisted.
The authorized capital of Remark Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.18 M.
The compliance status of Remark Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX